Trial intelligence / Profile preview

GnRH agonist vs GnRH antagonist in infertility treatment for endometriosis

IRCT20230403057803N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
May 2023
Countries
1
01

Overview

Phase 3 trial of relugolix in infertility (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started May 2023; status: completed.

02

Drugs

relugolix
03

Conditions

infertility

Beyond the preview

Go deeper on IRCT20230403057803N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230403057803N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call